{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:17:29Z","timestamp":1790360249347,"version":"4.1.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,25]],"date-time":"2020-10-25T00:00:00Z","timestamp":1603584000000},"content-version":"am","delay-in-days":359,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.drugalcdep.2019.06.011","type":"journal-article","created":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T11:37:31Z","timestamp":1567165051000},"page":"107508","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"special_numbering":"C","title":["Prevalence of New Psychoactive Substances (NPS) and conventional drugs of abuse (DOA) in high risk populations from Paris (France) and its suburbs"],"prefix":"10.1016","volume":"204","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9015-5342","authenticated-orcid":false,"given":"I.A.","family":"Larabi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Fabresse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Etting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Nadour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Pfau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.H.","family":"Raphalen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Philippe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Edel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5344-9475","authenticated-orcid":false,"given":"J.C.","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2019.06.011_bib0005","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/dta.1924","article-title":"The prevalence of new psychoactive substances in biological material - a three-year review of casework in Poland","volume":"8","author":"Adamowicz","year":"2016","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.drugalcdep.2019.06.011_bib0010","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.forsciint.2016.11.028","article-title":"Identification and quantification of 4-methylethcathinone (4-MEC) and 3,4-methylenedioxypyrovalerone (MDPV) in hair by LC-MS\/MS after chronic administration","volume":"270","author":"Alvarez","year":"2016","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.drugalcdep.2019.06.011_bib0015","first-page":"64","article-title":"Identification and quantification of diphenidine in hair by LC-MS\/MS after single administration","volume":"29","author":"Alvarez","year":"2016","journal-title":"Toxicol. Anal. Clin."},{"key":"10.1016\/j.drugalcdep.2019.06.011_bib0020","first-page":"7","article-title":"Synthetic cannabinoids and cathinones: prevalence and markets","volume":"25","author":"Bretteville-Jensen","year":"2013","journal-title":"Forensic Sci. Rev."},{"key":"10.1016\/j.drugalcdep.2019.06.011_bib0025","first-page":"S13","article-title":"O21: testing for 18 synthetic cannabinoids in hair using HPLC-MS\/MS: method development and validation, its application to authentic samples and preliminary results","volume":"26","author":"Cirimele","year":"2014","journal-title":"Toxicol. Anal. Clin."},{"key":"10.1016\/j.drugalcdep.2019.06.011_bib0030","series-title":"Cold and Cough Medicines","author":"Cold and Cough Medicines","year":"2015"},{"key":"10.1016\/j.drugalcdep.2019.06.011_bib0035","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.chroma.2015.04.002","article-title":"Simultaneous determination of 40 novel psychoactive stimulants in urine by liquid chromatography-high resolution mass spectrometry and library matching","volume":"1397","author":"Concheiro","year":"2015","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.drugalcdep.2019.06.011_bib0040","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0376-8716(02)00243-0","article-title":"Patterns of use and harms associated with non-medical ketamine use","volume":"69","author":"Dillon","year":"2003","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2019.06.011_bib0045","series-title":"Synthetic Cathinones Profile","author":"European Monitoring Centre for Drugs and Drug Addiction","year":"2019"},{"key":"10.1016\/j.drugalcdep.2019.06.011_bib0050","series-title":"European Drug Report 2018: Trends and Developments","author":"European Monitoring Centre for Drugs and Drug Addiction","year":"2018"},{"key":"10.1016\/j.drugalcdep.2019.06.011_bib0055","series-title":"4-Methylethcathinone (4-MEC) Critical Review Report","author":"Expert Committee on Drug Dependence","year":"2016"},{"key":"10.1016\/j.drugalcdep.2019.06.011_bib0060","series-title":"Dextromethorphan Pre-Review Report","author":"Expert Committee on Drug Dependence","year":"2012"},{"key":"10.1016\/j.drugalcdep.2019.06.011_bib0065","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/dta.2535","article-title":"Development of a sensitive untargeted LC-HRMS screening devoted to hair analysis through a shared MS2 spectra database: a step towards early detection of new psychoactive substances","volume":"11","author":"Fabresse","year":"2019","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.drugalcdep.2019.06.011_bib0070","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.forsciint.2016.01.039","article-title":"Detection of 3-methylmethcathinone and its metabolites 3-methylephedrine and 3-methylnorephedrine in pubic hair samples by liquid chromatography-high resolution\/high accuracy Orbitrap mass spectrometry","volume":"265","author":"Frison","year":"2016","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.drugalcdep.2019.06.011_bib0075","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1556-4029.2012.02254.x","article-title":"A fatality following ingestion of the designer drug meta-chlorophenylpiperazine (mCPP) in an asthmatic--HPLC-MS\/MS detection in biofluids and hair","volume":"58","author":"Gaillard","year":"2013","journal-title":"J. Forensic Sci."},{"key":"10.1016\/j.drugalcdep.2019.06.011_bib0080","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.forsciint.2014.04.038","article-title":"Toxicological findings in a fatal multidrug intoxication involving mephedrone","volume":"243","author":"Gerace","year":"2014","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.drugalcdep.2019.06.011_bib0085","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.forsciint.2015.07.040","article-title":"Detection of synthetic cathinones in victims of sexual assault","volume":"257","author":"Hagan","year":"2015","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.drugalcdep.2019.06.011_bib0090","series-title":"Monitoring the Future: National Results on Adolescent Drug Use. Overview of Key Findings 2006","author":"Johnston","year":"2007"},{"key":"10.1016\/j.drugalcdep.2019.06.011_bib0095","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.forsciint.2010.04.007","article-title":"Estimation of illicit drugs consumption by wastewater analysis in Paris area (France)","volume":"200","author":"Karolak","year":"2010","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.drugalcdep.2019.06.011_bib0100","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/dar.12058","article-title":"Novel psychoactive drug use among younger adults involved in US nightlife scenes","volume":"32","author":"Kelly","year":"2013","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.drugalcdep.2019.06.011_bib0105","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/dta.313","article-title":"Cathinone derivatives: a review of their chemistry, pharmacology and toxicology","volume":"3","author":"Kelly","year":"2011","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.drugalcdep.2019.06.011_bib0110","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s13643-016-0375-5","article-title":"The prevalence of novel psychoactive substances (NPS) use in non-clinical populations: a systematic review protocol","volume":"5","author":"Khaled","year":"2016","journal-title":"Syst. Rev."},{"key":"10.1016\/j.drugalcdep.2019.06.011_bib0115","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1248\/yakushi.12-00247-6","article-title":"Prevalence of new designer drugs and their legal status in Japan","volume":"133","author":"Kikura-Hanajiri","year":"2013","journal-title":"Yakugaku Zasshi"},{"key":"10.1016\/j.drugalcdep.2019.06.011_bib0120","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jpba.2014.09.013","article-title":"Simultaneous determination of five naphthoylindole-based synthetic cannabinoids and metabolites and their deposition in human and rat hair","volume":"102","author":"Kim","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.drugalcdep.2019.06.011_bib0125","doi-asserted-by":"crossref","first-page":"658","DOI":"10.2174\/1570159X14666161026152107","article-title":"Evidence of 2 populations of mephedrone abusers by hair testing. Application to 4 forensic expertises","volume":"15","author":"Kintz","year":"2017","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.drugalcdep.2019.06.011_bib0130","series-title":"Hair Analysis in Clinical and Forensic Toxicology","author":"Kintz","year":"2015"},{"key":"10.1016\/j.drugalcdep.2019.06.011_bib0135","first-page":"S47","article-title":"D\u00e9termination du fluorofentanyl et du furanylfentanyl dans les cheveux par LC-MS\/MS suite \u00e0 une overdose aux opio\u00efdes : \u00e0 propos d\u2019un cas","volume":"30","author":"Larabi","year":"2018","journal-title":"Toxicol. Anal. Clin."},{"key":"10.1016\/j.drugalcdep.2019.06.011_bib0140","doi-asserted-by":"crossref","DOI":"10.1002\/dta.2377","article-title":"Drug-facilitated sexual assault (DFSA) involving 4-methylethcathinone (4-MEC), 3,4-Methylenedioxypyrovalerone (MDPV), and doxylamine highlighted by hair analysis","author":"Larabi","year":"2018","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.drugalcdep.2019.06.011_bib0145","first-page":"S52","article-title":"D\u00e9c\u00e8s accidentel \u00e0 la suite d\u2019une injection de B2 Ultra","volume":"30","author":"Lelong","year":"2018","journal-title":"Toxicol. Anal. Clin."},{"key":"10.1016\/j.drugalcdep.2019.06.011_bib0150","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/dta.1948","article-title":"An LC-MS\/MS methodological approach to the analysis of hair for amphetamine-type-stimulant (ATS) drugs, including selected synthetic cathinones and piperazines","volume":"9","author":"Lendoiro","year":"2017","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.drugalcdep.2019.06.011_bib0155","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1093\/jat\/29.5.314","article-title":"Evaluation of ketamine abuse using hair analysis: concentration trends in a Singapore population","volume":"29","author":"Leong","year":"2005","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.drugalcdep.2019.06.011_bib0160","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.forsciint.2011.10.016","article-title":"Evidence of mephedrone chronic abuse through hair analysis using GC\/MS","volume":"218","author":"Martin","year":"2012","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.drugalcdep.2019.06.011_bib0165","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1007\/s00204-016-1764-1","article-title":"High-resolution mass spectrometry in toxicology: current status and future perspectives","volume":"90","author":"Maurer","year":"2016","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.drugalcdep.2019.06.011_bib0170","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jchromb.2013.10.021","article-title":"Simple segmental hair analysis for \u03b1-pyrrolidinophenone-type designer drugs by MonoSpin extraction for evaluation of abuse history","volume":"942\u2013943","author":"Namera","year":"2013","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.drugalcdep.2019.06.011_bib0175","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/s11419-013-0192-7","article-title":"A fatal case of 3,4-methylenedioxypyrovalerone poisoning: coexistence of \u03b1-pyrrolidinobutiophenone and \u03b1-pyrrolidinovalerophenone in blood and\/or hair","volume":"31","author":"Namera","year":"2013","journal-title":"Forensic Toxicol."},{"key":"10.1016\/j.drugalcdep.2019.06.011_bib0180","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.drugpo.2014.09.010","article-title":"Drug analysis of residual content of used syringes: a new approach for improving knowledge of injected drugs and drug user practices","volume":"26","author":"N\u00e9fau","year":"2015","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2019.06.011_bib0185","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.drugalcdep.2015.08.028","article-title":"Self-reported use of novel psychoactive substances in a US nationally representative survey: prevalence, correlates, and a call for new survey methods to prevent underreporting","volume":"156","author":"Palamar","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2019.06.011_bib0190","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3109\/00952990.2015.1106551","article-title":"Characteristics of novel psychoactive substance exposures reported to New York City Poison Center, 2011-2014","volume":"42","author":"Palamar","year":"2016","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"10.1016\/j.drugalcdep.2019.06.011_bib0195","first-page":"5511","article-title":"Mephedrone concentrations in cases of clinical intoxication","volume":"23","author":"Papaseit","year":"2017","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.drugalcdep.2019.06.011_bib0200","doi-asserted-by":"crossref","DOI":"10.1088\/1752-7155\/10\/1\/012001","article-title":"High-resolution mass spectrometry: basic principles for using exact mass and mass defect for discovery analysis of organic molecules in blood, breath, urine and environmental media","volume":"10","author":"Pleil","year":"2016","journal-title":"J. Breath Res."},{"key":"10.1016\/j.drugalcdep.2019.06.011_bib0205","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/jat\/bkw048","article-title":"Two fatal intoxications involving butyryl fentanyl","volume":"40","author":"Poklis","year":"2016","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.drugalcdep.2019.06.011_bib0210","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.forsciint.2011.04.020","article-title":"The analysis of substituted cathinones. Part 1: chemical analysis of 2-, 3- and 4-methylmethcathinone","volume":"212","author":"Power","year":"2011","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.drugalcdep.2019.06.011_bib0215","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/jat.837","article-title":"Development and validation of a high-performance liquid chromatography method for the determination of cocaine, its metabolites and ketamine","volume":"22","author":"Rofael","year":"2002","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.drugalcdep.2019.06.011_bib0220","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/dta.1615","article-title":"Cathinones derivatives-related deaths as exemplified by two fatal cases involving methcathinone with 4-methylmethcathinone and 4-methylethcathinone","volume":"6","author":"Rojek","year":"2014","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.drugalcdep.2019.06.011_bib0225","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/dta.1338","article-title":"Prevalence of new psychoactive substances: a retrospective study in hair","volume":"4","author":"Rust","year":"2012","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.drugalcdep.2019.06.011_bib0230","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1007\/s00216-015-9247-4","article-title":"Determination of cathinones and other stimulant, psychedelic, and dissociative designer drugs in real hair samples","volume":"408","author":"Salomone","year":"2016","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.drugalcdep.2019.06.011_bib0235","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.forsciint.2014.12.030","article-title":"Cut-off proposal for the detection of ketamine in hair","volume":"248","author":"Salomone","year":"2015","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.drugalcdep.2019.06.011_bib0240","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/jms.2988","article-title":"Simultaneous analysis of several synthetic cannabinoids, THC, CBD and CBN, in hair by ultra-high performance liquid chromatography tandem mass spectrometry. Method validation and application to real samples","volume":"47","author":"Salomone","year":"2012","journal-title":"J. Mass Spectrom."},{"key":"10.1016\/j.drugalcdep.2019.06.011_bib0245","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/dta.1556","article-title":"Hair analysis as a tool to evaluate the prevalence of synthetic cannabinoids in different populations of drug consumers","volume":"6","author":"Salomone","year":"2014","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.drugalcdep.2019.06.011_bib0250","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1093\/jat\/bkx020","article-title":"Hair testing for drugs of abuse and new psychoactive substances in a high-risk population","volume":"41","author":"Salomone","year":"2017","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.drugalcdep.2019.06.011_bib0255","first-page":"248","article-title":"A fatal case involving several synthetic cannabinoids","volume":"80","author":"Schaefer","year":"2013","journal-title":"Toxichem. Krimtech."},{"key":"10.1016\/j.drugalcdep.2019.06.011_bib0260","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s00216-014-8118-8","article-title":"Nontargeted SWATH acquisition for identifying 47 synthetic cannabinoid metabolites in human urine by liquid chromatography-high-resolution tandem mass spectrometry","volume":"407","author":"Scheidweiler","year":"2015","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.drugalcdep.2019.06.011_bib0265","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/hup.2300","article-title":"Novel psychoactive substances as a novel challenge for health professionals: results from an Italian survey","volume":"28","author":"Simonato","year":"2013","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2019.06.011_bib0270","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0379-0738(03)00048-3","article-title":"Determination of cathinone, cathine and norephedrine in hair of Yemenite khat chewers","volume":"133","author":"Sporkert","year":"2003","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.drugalcdep.2019.06.011_bib0275","first-page":"114","article-title":"Surveillance of emerging drugs of abuse in Hong Kong: validation of an analytical tool","volume":"21","author":"Tang","year":"2015","journal-title":"Hong Kong Med. J."},{"key":"10.1016\/j.drugalcdep.2019.06.011_bib0280","series-title":"Global Synthetic Drugs Assessment. Amphetamine-Type Stimulants and New Psychoactive Substances","author":"United Nations Office on Drugs and Crime","year":"2017"},{"key":"10.1016\/j.drugalcdep.2019.06.011_bib0285","series-title":"The Challenge of New Psychoactive Substances. Global SMART Programme","author":"United Nations Office on Drugs and Crime","year":"2013"},{"key":"10.1016\/j.drugalcdep.2019.06.011_bib0290","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1093\/jat\/34.9.594","article-title":"Two fatal intoxications with the new designer drug methedrone (4-methoxymethcathinone)","volume":"34","author":"Wikstr\u00f6m","year":"2010","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.drugalcdep.2019.06.011_bib0295","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/jat\/bkt001","article-title":"Postmortem tissue distribution of MDPV following lethal intoxication by \u201cbath salts.\u201d","volume":"37","author":"Wyman","year":"2013","journal-title":"J. Anal. Toxicol."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871619302674?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871619302674?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T09:04:20Z","timestamp":1759827860000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871619302674"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":59,"alternative-id":["S0376871619302674"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.06.011","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence of New Psychoactive Substances (NPS) and conventional drugs of abuse (DOA) in high risk populations from Paris (France) and its suburbs","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107508"}}